| Tight junction (cell polarity; muscle cell development) |
3 |
0.006 |
MYH4, MYH1, MYH10 |
| GABAergic synapse |
2 |
0.025 |
SLC6A1, PLCL1 |
| Synthesis and degradation of ketone bodies (ketone bodies degraded to acetyl-CoA for fatty acids synthesis) |
1 |
0.032 |
BDH1 |
| Oxytocin signaling pathway (cell proliferation; contraction) |
2 |
0.067 |
ROCK2, CDKN1A |
| Butanoate metabolism (Acetyl-CoA for fatty acids synthesis) |
1 |
0.076 |
BDH1 |
| Purine metabolism |
2 |
0.086 |
ENSBTAG00000045889 (pseudogene), AMPD1 |
| Galactose metabolism (glycerol for fatty acids synthesis) |
1 |
0.087 |
GANC |
| Linoleic acid metabolism (fatty acid metabolism) |
1 |
0.094 |
CYP2R1 |
| Pyruvate metabolism (linked to fatty acid biosynthesis through Malonyl-CoA |
1 |
0.101 |
ME2 |
| Bladder cancer (X) |
1 |
0.101 |
CDKN1A |
| Proteoglycans in cancer (cell growth) |
2 |
0.107 |
ROCK2, CDKN1A |
| Metabolic pathways |
6 |
0.125 |
ALDH1A1, AMPD1, ENSBTAG00000045889 (pseudogene), GANC, CYP2R1, BDH1 |
